MedTrace Logo

Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers.

NCT01276990 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2012-02-09

No results posted yet for this study

Summary

To investigate the safety and pharmacokinetic of BI 224436 in healthy male volunteers following oral administration of repeated doses for 10 days within 8 dosing regimens.

Conditions

  • HIV Infections
  • Healthy

Interventions

DRUG

BI 224436

Oral drinking solution

DRUG

BI 224436

Oral drinking solution

DRUG

BI 224436

Oral drinking solution

DRUG

BI 224436

Oral drinking solution

DRUG

BI 224436

Oral drinking solution

DRUG

BI 224436

Oral drinking solution

DRUG

BI 224436

Oral drinking solution

DRUG

BI 224436

Oral drinking solution

DRUG

BI 224436

Oral drinking solution

DRUG

Placebo

Oral drinking solution

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-09-30

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01276990 on ClinicalTrials.gov